Abbott Laboratories Stock NEO Exchange
Stocks
ABT
CA0028221046
Medical Equipment, Supplies & Distribution
| Market Cap | 172B 150B 139B 128B 241B 16,578B 247B 1,659B 653B 8,119B 646B 632B 27,950B | P/E 2026 * |
26.1x | P/E 2027 * | 21.4x |
|---|---|---|---|---|---|
| Enterprise Value | 195B 170B 157B 145B 273B 18,752B 279B 1,877B 738B 9,184B 731B 715B 31,616B | EV / Sales 2026 * |
3.87x | EV / Sales 2027 * | 3.4x |
| Free-Float |
86.73% | Yield 2026 * |
2.58% | Yield 2027 * | 2.75% |
Last Transcript: Abbott Laboratories
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 172B | |
| -0.79% | -1.13% | -7.38% | -4.37% | 107B | |
| +0.06% | +1.57% | +4.69% | +60.40% | 59.92B | |
| -1.34% | +3.85% | -12.78% | -38.52% | 44.07B | |
| -2.74% | -2.37% | - | - | 34.76B | |
| -1.65% | +1.97% | -9.11% | -44.39% | 30.09B | |
| -0.61% | +2.30% | +63.29% | -5.68% | 25.61B | |
| -0.91% | +1.31% | -3.73% | -18.94% | 20.86B | |
| -1.41% | +0.84% | -3.02% | -4.62% | 21.55B | |
| +2.74% | +1.80% | -6.96% | +4.13% | 20.04B | |
| Average | -0.66% | +2.65% | +3.13% | -6.50% | 40.43B | |
| Weighted average by Cap. | -0.54% | +2.50% | -0.02% | -1.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.33B 43.99B 40.59B 37.41B 70.52B 4,847B 72.08B 485B 191B 2,374B 189B 185B 8,172B | 54.67B 47.77B 44.08B 40.63B 76.59B 5,265B 78.29B 527B 207B 2,578B 205B 201B 8,876B |
| Net income | 6.84B 5.97B 5.51B 5.08B 9.58B 658B 9.79B 65.88B 25.91B 322B 25.67B 25.11B 1,110B | 8.1B 7.08B 6.53B 6.02B 11.34B 780B 11.6B 78.05B 30.7B 382B 30.41B 29.74B 1,315B |
| Net Debt | 22.58B 19.73B 18.21B 16.79B 31.64B 2,175B 32.34B 218B 85.61B 1,065B 84.81B 82.95B 3,666B | 13.59B 11.88B 10.96B 10.1B 19.04B 1,309B 19.46B 131B 51.52B 641B 51.04B 49.92B 2,206B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
